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Abstract
Background: Research suggests that an eight-week Mindfulness-Based Cognitive Therapy (MBCT) program may be
effective in the treatment of generalized anxiety disorders. Our objective is to compare the clinical effectiveness of
the MBCT program with a psycho-education programme and usual care in reducing anxiety symptoms in people
suffering from generalized anxiety disorder.
Methods: A three armed randomized, controlled clinical trial including 9-month post-treatment follow-up is
proposed. Participants screened positive using the Structure Clinical Interview for DSM-IV (SCID) for general anxiety
disorder will be recruited from community-based clinics. 228 participants will be randomly allocated to the MBCT
program plus usual care, psycho-education program plus usual care or the usual care group. Validated Chinese
version of instruments measuring anxiety and worry symptoms, depression, quality of life and health service
utilization will be used. Our primary end point is the change of anxiety and worry score (Beck Anxiety Inventory
and Penn State Worry Scale) from baseline to the end of intervention. For primary analyses, treatment outcomes
will be assessed by ANCOVA, with change in anxiety score as the baseline variable, while the baseline anxiety score
and other baseline characteristics that significantly differ between groups will serve as covariates.
Conclusions: This is a first randomized controlled trial that compare the effectiveness of MBCT with an active
control, findings will advance current knowledge in the management of GAD and the way that group intervention
can be delivered and inform future research.
Unique Trail Number (assigned by Centre for Clinical Trails, Clinical Trials registry, The Chinese University of Hong
Kong): CUHK_CCT00267
Background
Generalized anxiety disorder (GAD) is one of the most
common mental health problems seen in the primary
care or community setting [1] and is associated with sig-
nificant disability and high utilization of health services
[2]. According to established evidence [3], medication or
cognitive behavioral therapy are the first line treatments
for its management. However, side - effects and costs
associated with medications can be barriers to treat-
ments and individual cognitive behavioral therapy can
be expensive and time consuming. In addition, for both
medication and cognitive behavioral therapy, persistence
of residual symptoms continues to be an issue even for
those who respond to these treatments initially [2]. As a
result, there is a need to use other treatment that falls
between a minimalist and intensive approach that can
reduce patients’ symptoms and health care utilization.
One recently established intervention is mindfulness
based cognitive therapy based on mindfulness medita-
tion, modelled after the mindfulness-based stress reduc-
tion (MBSR) programme [4] at the University of
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in a particular way on purpose, in the present moment
and non-judgmentally.”[4] For example, a mindful
approach to one’s inner experience is simply viewing
“thoughts as thoughts” as opposed to evaluating certain
thoughts as positive or negative.
Mindfulness Based Cognitive Therapy (MBCT) (for-
merly called attentional control) is a theory driven treat-
ment approach developed by Zindel Segal, Mark
Williams and John Teasdale with the aim to discover a
cost-effective treatment approach to significantly reduce
relapse and recurrence of major depression [5]. Cogni-
tive therapy techniques involved in MBCT include edu-
cation about mood symptoms, the role of negative
thoughts, and how rumination, avoidance, suppression,
and struggling with unhelpful cognitions and emotions
can perpetuate distress rather then resolve it. MBCT
emphasizes acceptance rather than change strategies
and offers no training in changing the content of think-
ing but rather seeing thoughts as thoughts rather than
as reflections of reality (meta-cognitive awareness) [6].
Recently, MBCT has been suggested as a therapy for
treating anxiety symptoms [7] since training in present
moment mindful awareness may provide a useful way of
responding for individuals with generalized anxiety.
Although it has been shown in randomized controlled
clinical trials that MBCT can reduce the likelihood of
relapse in people with recurrent episodes of depression
[8,9], the evidence for the effectiveness of MBCT in
reducing anxiety symptoms among people with anxiety
disorder is less well established. So far, three pilot stu-
dies, one that employed mixed methodology and studies
with a pre and post intervention design have been
conducted.
In an exploratory mixed qualitative and quantitative
study, Finucane & Mercer [10] showed that the use of
mindfulness based cognitive therapy for patients with
active anxiety symptoms in primary care was both
acceptable and beneficial to majority of patients in his
study and more than half of the patients in the study
continued to apply mindfulness techniques 3 months
after the course had ended. In a study by Evans et al
[11] that employed a pre and post intervention (without
control) design, they showed that there were significant
reductions in anxiety and depressive symptoms post
intervention in patients with generalized anxiety disor-
ders. Recently, Yook et al [12] showed that there were
significant improvements in Pittsburgh Sleep Quality
Index, Penn State Worry Questionnaire, Ruminative
Response Scale, Hamilton Anxiety Rating Scale and
Hamilton Depression Rating Scale scores at the end of
the 8-week program when compared to scores at base-
line. However, all these studies were pilot studies with
small sample size that ranges from 11-22 participants
and with no control group which makes it hard to draw
conclusion on the effectiveness of MBCT in treating
anxiety symptoms.
Research objectives
Primary Objectives
T h ep r i m a r yo b j e c t i v eo ft h es t u d yi st oe v a l u a t et h e
superior effects of MBCT in reducing anxiety symptoms
in patients with generalized anxiety disorder from the
community and primary care at 9 months when com-
pared to Psycho-Education Group using cognitive beha-
vioural therapy and Usual Care (UG) groups.
Secondary objectives
The secondary objectives of this study are to evaluate
the effects of MBCT on:
￿ Patients’ reduction of worry symptoms post inter-
vention at 9 months
￿ Patients’ reduction of depressive symptoms post
intervention at 9 months
￿ Patients’ reduction of the use of psychiatric medica-
tion post intervention at 9 months
￿ Patients’ increase in quality of life post intervention
at 9 months
￿ Patients’ reduction in use of health service post
intervention at 9 months
￿ Patients’ reduction in leave of absence from work
post intervention at 9 months
Methods and Design
The current study protocol was approved by the Joint
Chinese University of Hong Kong and New Territories
East Cluster (CUHK-NTEC) Clinical Research Ethics
Committee (CREC).
This study is a randomized controlled trial with three
study arms: the MBCT programme led by trained
MBCT instructors, Psycho-Education Group (PEG)
using CBT principles led by clinical psychologist, and
usual care (UC) which will be offered MBCT at the end
of the study for ethical reasons. The MBCT and group
PEG consist of eight 2-hour weekly sessions. Outcome
measures of all participants will be collected at similar
time points (baseline, immediately post intervention,
and at 3, 6 and 9 months post intervention). The pre-
vious studies that evaluated the effectiveness of MBCT
for anxiety did not employed a control group; the inclu-
sion of comparison groups, a usual care group and
PEG, will be important in evaluating the benefits of
MBCT.
Three instructors with at least two-year experience in
teaching MBSR or MBCT will lead the MBCT groups
while three clinical psychologists with at least master
degree in clinical psychology will be hired for conduct-
ing the PEG.
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Entry criteria for the current proposed study will include
all of the followings:
1) being 21-65 years of age; 2) having, at baseline
assessment, a DSM-IV TR principal diagnosis of gener-
alized anxiety disorder on SCID (Structured Clinical
Interview for DSM-IV) [13] and a score of 19 or above
using the Chinese version of the Beck Anxiety Inventory
[14]; 3) can understand Cantonese; 4) are willing to
attend either the mindfulness based cognitive therapy
program or the group cognitive behavioural therapy; 5)
if patient is on medication for his/her condition, he or
s h es h o u l db eo ns t a b l ed o s e so fm e d i c a t i o nf o r3
months before starting treatment.
Exclusion criteria will include any one of the follow-
ings: 1) illiterate subjects as they will not be able to
complete the homework diary; 2) psychiatric and medi-
cal comorbidities that are potentially life threatening (i.e.
psychosis, suicidal ideation, terminal medical illness) or
those expected to severely limit patient participation or
adherence (e.g. psychosis, current substance abuse,
dementia, pregnancy); 3) those who are currently seeing
a cognitive behavioural therapist or psychotherapists/
counsellors.
Patients will be recruited from: 1) referral from doc-
tors who work in the General Outpatient Clinics
(GOPC) of the New Territories East Cluster of the Hos-
pital Authority and who are interested in this study; 2)
review of those who have been referred to be seen by a
psychiatrist for anxiety symptoms and who are on the
wait list to be seen for at least 12 months (currently
there are more than 500 patients in this category with a
majority stating that their major complaint is anxiety);.
3) a website set up by the University that provide
health-related information which is available to general
public.
All interested subjects will be screened on phone by a
trained research assistant to determine eligibility in
accordance to the pre-set inclusion and exclusion cri-
teria. Those eligible subjects will then be scheduled to
have a diagnostic interview with a family physician; the
family physician will further confirm the eligibly with
the Structured Clinical Interview for DSM-IV SCID
[13]. Both the family physician and the research assis-
tant are trained to use the DSM-IV SCID with a psy-
chiatrist. All eligible part i c i p a n t sw i l lb es e e nb yt h e
principal investigator (PI) 1-4 weeks before the start of
the interventions to further explain the study, to con-
firm eligibility, and provide informed consent.
A statistician who is not involved in any part of the
study independently randomized participants by using a
predetermined random table generated by Microsoft
Excel 2002. These numbers will not be decoded until
the intervention group is assigned.
The allocation is concealed from the researchers, who
carries out the baseline assessment or recorded the data,
and the statistician who carried out the analysis. The
allocation is unknown to the participants until the first
appointment.
The research study has been approved by the Joint
Chinese University of Hong Kong-New Territory East
Cluster (CUHK-NTEC) Ethics Committee.
Mindfulness Based Cognitive Therapy (MBCT) plus usual
care - treatment arm
After an initial individual orientation session, the MBCT
program will be delivered by an instructor who has been
trained in mindfulness based cognitive therapy and who
has more than 2 years of training experience in MBCT.
One programme of 18 participants will be conducted
for 8 weeks with 2 hours group training sessions. The
programme will include daily homework exercises which
will include guided (taped) or unguided awareness exer-
cises directed at increasing moment by moment non-
judgmental awareness of bodily sensations, thoughts,
and feelings together with exercises designed to inte-
grate application of awareness skills into daily life. Key
themes of MBCT include empowerment of participants
and a focus on awareness and acceptance of experience
in the moment. Participants are helped to develop a
“decentred” perspective on thoughts and feelings, in
which these are viewed as passing events in the mind.
Psycho-Education Programme based on cognitive
behavioural therapy principle - active control arm
The Psycho-Education Programme is designed to be
comparable to MBCT in level of structure, therapist’s
contact and attention, with participants required to
adhere to an agenda during sessions with homework
assignments of similar duration. It will consist of a series
of 8 weekly 2-hour sessions. The sessions are based on
White’s book on Treating Anxiety and Stress [15]. All
instructors will be qualified clinical psychologists with
training in cognitive behavioral therapy.
Usual care control (UC)
Usual care refers to primary or community care used by
participants. In Hong Kong, the majority of primary
care is provided by the private sector with around 20%
provided by public outpatient clinics. In general, patients
who use public outpatient clinics tend to be older, with
chronic conditions and who are from a lower socio-eco-
nomic status.
As the consultation time is usually short (usually one
doctor sees about 40-45 patients in one morning), they
may be lack of time to deal with patients who present
with emotional problems. As a result, usual care can
mean minimal care especially if the patients are from
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to test the effectiveness of MBCT against minimal inter-
vention. All controls will be offered MBCT after the end
of the study for ethical reasons.
Measures at baseline and each follow-up: Subjects’
demographic data including age, sex, marital status, edu-
cation status, personal monthly income, religious belief,
and all other outcome measures (described below), use
of medication (including psychotropics), and experience
with mindfulness and yoga, together with medical his-
tory including psychiatric history will be collected by a
trained interviewer. After the baseline visit, subjects will
be randomized as described above. The fidelity of the
intervention will be ensured and monitored by a ran-
dom review of audiotapes that are recorded during all
sessions.
Outcome measures
These will be measured at baseline and at 8 weeks (end
of intervention) and will be repeated at 3 months and 6
months and 9 months after intervention.
Primary outcome measures
Anxiety symptoms will be measured using the validated
Chinese version Penn State Worry Questionnaire [16]
and the Chinese version Beck Anxiety Inventory [17].
The use of two validated questionnaire is to improve
validity of findings. The Penn State Worry Question-
n a i r ei sam e a s u r eo fw o r r yp h e n o m e n aa n dh a sb e e n
demonstrated valid in cross-cultural populations. In a
study that examined the factor structure and psycho-
metric properties of the Chinese version of PSWQ, this
scale has been shown to have good internal consistency,
and both convergent and discriminate validity [18]. The
Beck Anxiety Inventory (BAI) is the measure most fre-
quently used to assess the construct of anxiety. It is a
popular measure due to its efficient, cost-effective and
easy to administer, complete and interpret with good
reliability and internal consistency [17].
Secondary outcome measures
Depressive symptoms will be measured by the vali-
dated Chinese version of the Centre for Epidemiologi-
cal Studies-Depression Scale (CES-D) [19]. Health
related quality of life will be measured by the validated
Chinese version Medical Outcomes Study Short-Form
Health Survey (SF-12) [20]. The SF-12 is a 12-item
survey that reports health-related quality of life,
including both physical and mental functioning and
well-being. It has shown to be a valid measure for
measuring health related quality of life in local Chinese
population.
“Mindfulness” will be measured by the Five Facet
Mindfulness Questionnaire [21].
Health service utilization and medication use: Utiliza-
tion of health services including visits to primary care
doctors (both private and public) and hospitalizations
and the number of days of absence from work attributa-
ble to anxiety will be recorded at 4 weekly intervals by
the trained research assistant using telephone. The fre-
quency and duration of practice of both MBSR and PEG
in each group will be documented by a Weekly Home-
work Form that will be collected each week during class
and at 3 month interval until the end of 9 month post
intervention. Moreover, medication use including
changes in medication will be monitored at 3 month
interval. Response rate (enrolment of subjects), retention
rate (number and proportion attended each class) of the
MBCT and the psycho-education group will be
documented.
Data and statistical analysis
Baseline characteristics of the three groups will be com-
pared by ANOVA test for continuous variables and chi-
square test for categorical variables. The baseline factors
will include age, sex, medication status, psychological
and lifestyle characteristics. Our primary end point is
t h ec h a n g eo fa n x i e t ya n dw o r r ys c o r e( B A Ia n dP e n n
State Worry Scale) from baseline to the end of interven-
tion. Secondary outcomes included the change in scores
of CES-D and SF-12. For primary analyses, treatment
outcomes will be assessed by ANCOVA, with change in
anxiety score as the baseline variable, while the baseline
anxiety score and other baseline characteristics that sig-
nificantly difference between groups will serve as covari-
ates. A two-sided P value of 0.05 or less will be
considered be statistically significant. For secondary ana-
lyses, the three groups will be simultaneously taken into
the analysis of variance model for repeated measures.
The baseline measurement of anxiety symptoms and
any significant secondary outcome variables will be
entered into the model as a covariate as they are consid-
ered to be confounders. Analysis will also be performed
on an “intention to treat” analysis.
Since there have been no studies on MBCT with an
active control that control for contact time and atten-
tion, we need to use the only available study on GAD
with an active control by Wetherell et al [22] for sample
size calculation. The null hypothesis for this study is
that there will be no improvement in the outcome mea-
sures in the MBCT group relative to other groups and
we will test this hypothesis using a one-sided analysis.
Assuming that the average change of mean score of
BAI of patients in MBCT is 5.6 (7.4), in the discussion
group is 2.0 (7.4) and that in usual care control is 1.1
(7.4) with a 1-sided type I error of 5% and 80% power
to detect statistical significant differences between the
MBCT and psycho-education group as well as MBCT
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subjects in each group. We set our enrolment target at
228 subjects.
Discussion
This will be the first study conducted to investigate the
usefulness of MBCT using a control group in the treat-
ment of anxiety symptoms in those with generalized
anxiety disorder. One of the key strengths of this pro-
posed study when compared to previous studies in this
field is the use of an active control group since most of
the previous studies have only employed a pre-post
design or lack of an active controls.
Since the active control group is conducted by psy-
chologists using CBT principles, which is the current
recommended low intensity intervention by the National
Institute of Clinical Excellence (NICE) for patients with
GAD who suffer from milder symptoms of anxiety in
the UK, the results of this trial will advance current
knowledge in the management of GAD and the way
that group intervention can be delivered and inform
future research. One of the advantages of MBCT is the
potential for having larger number of participants when
compared to normal CBT group (range from 6-8). In
this study, we plan to have larger group size than group
size previously adopted by previous investigators of
MBCT trial.
If MBCT is shown to be effective in reducing partici-
pants’ symptoms, further economic analysis can be con-
ducted to further evaluate the cost-effectiveness of this
intervention. Moreover, it can be further disseminated
in various primary and community settings for helping
patients with GAD in the community.
Limitations
Participants who volunteer for the study could be biased
towards non-pharmacological treatment and those who
a r ea s s i g n e dt ot h eu s u a lc a r eg r o u pm a yb ed i s a p -
pointed and drop out from the study. Although we will
offer MBCT at the end of the study, the attrition rate
for this group of participants is likely to be higher.
Further analysis of the demo-sociographic characteristics
of pateints who enrolled in our study will further inform
the generalizability of our findings.
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